Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 18 and up

Comparing two forms of tacrolimus for treating oral lichen planus

Official title: Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus - a Randomized Clinical Trial

Run by Hospital de Clinicas de Porto Alegre · NCT06591884 · Data updated 2026-11-12

This study is testing whether a new spray form of tacrolimus works better than the regular ointment for treating oral lichen planus.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment46 (estimated)
SponsorHospital de Clinicas de Porto Alegre
Academic / other
Locations1 site (Porto Alegre, Rio Grande do Sul)
StatusRecruiting
StartedSeptember 3, 2024
Main results expectedDecember 2027
Study endsDecember 2028
Registry record updatedOctober 2, 2024
Trial IDNCT06591884 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with erosive or ulcerative oral lichen planus.

Probably not a fit

Patients with a history of oral cancer, allergic reactions to tacrolimus, or significant immunosuppression may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a 0.08% tacrolimus nanoencapsulated aqueous solution spray versus a 0.1% free tacrolimus commercial ointment in treating oral lichen planus. Participants will apply one of the formulations twice daily for one month and attend clinic visits every two weeks for assessments. The study aims to determine which formulation leads to longer periods without lesions. The trial is designed to provide insights into the efficacy of different drug delivery methods for this condition.

Why it matters

Potential benefit: If successful, this study could offer a more effective treatment option for patients suffering from oral lichen planus.

How similar studies have gone: Other studies have explored tacrolimus for oral lichen planus, but the nanoencapsulation approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* individuals with a clinical and histopathological diagnosis of erosive/ulcerative/atrophic and symptomatic oral lichen planus, according to the criteria established by the American Academy of Oral and Maxillofacial Pathology

Exclusion Criteria:

* History of oral cancer;
* history of allergic reactions to tacrolimus or any other component of the formulas;
* history of organ transplant or have a systemic condition that induces significant immunosuppression;
* be pregnant or lactating.

Where it's running

  • Hospital de Clínicas de Porto Alegre
    Porto Alegre, Rio Grande do Sul, Brazil
    Recruiting

Study contacts

  • Principal investigator: Fernanda Visioli, DDS, PhD — Hospital de Clinicas de Porto Alegre
  • Study coordinator: Fernanda Visioli, DDS, PhD
  • Email: fvisioli@hcpa.edu.br
  • Phone: +55 51 3308-5011

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Cardio-oncology rehabilitation for women with breast cancer on chemotherapy

    This trial tests a cardio-oncology rehabilitation program to see if supervised exercise during chemotherapy helps heart health and function in women with breast cancer.

    Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT07823660

  • Brazilian Portuguese version of EmPHasis-10 for pulmonary hypertension

    This study tests a Brazilian Portuguese version of the EmPHasis-10 questionnaire to see if it reliably measures quality of life in adults with pulmonary hypertension in Porto Alegre, Brazil.

    Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre · NCT07822997

  • Diaphragm ultrasound to help wean from mechanical ventilation

    This study tests whether bedside ultrasound of the diaphragm can help decide if patients who fail their first spontaneous breathing trial can be weaned from invasive ventilation.

    Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT07751237

  • Pelvic Floor Therapy plus Exercise for Endometriosis-Related Pelvic Pain

    This 12-week study tests whether specialized pelvic floor physical therapy plus a structured exercise program helps reduce chronic pelvic pain in women with endometriosis more than a placebo version of pelvic floor therapy plus the same exercise plan.

    Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT07733583

  • How social deprivation relates to surgery outcomes in Brazil

    This study looks at whether poverty and social disadvantage affect perioperative outcomes for people having surgery in Brazil.

    Recruiting at 2 sites Hospital de Clinicas de Porto Alegre · Salvador, Estado de Bahia and 6 other locations · NCT07621211

  • Impact of quick pneumonia panel on antibiotic choices for hospitalized adults

    This study tests whether a rapid pneumonia panel can help doctors choose better antibiotics sooner for adults with hospital‑acquired or ventilator‑associated pneumonia.

    Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT07585604

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.